The chart below shows how HYPR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, HYPR sees a +10.74% change in stock price 10 days leading up to the earnings, and a -5.02% change 10 days following the report. On the earnings day itself, the stock moves by +2.65%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Quarterly Revenue Increase: Revenue for the quarter ended September 30, 2024 was $3.6 million, up 56% compared to the third quarter of 2023.
Revenue Increase Year-to-Date: Year-to-date, we've generated $10.6 million in revenue, up 27% from the first nine months of 2023.
Record Gross Margin Achievement: Gross profit for the third quarter of 2024 was $1.9 million compared to $1.1 million in the third quarter of 2023, resulting in a record gross margin of 52%.
Gross Profit Increase: Year-to-date, we've generated $5.1 million in gross profit, up 36% from the first nine months of 2023.
Updated MRI Standards: We expect the Inter-societal Accreditation Commission, IAC, a leading CMS approved accreditation body to issue updated MRI standards that include the use of portable point-of-care ultra-low field brain MRI.
Negative
Quarterly Revenue Surge: Revenue for the quarter ended September 30, 2024 was $3.6 million, up 56% compared to the third quarter of 2023, indicating a significant increase but still reflecting challenges in cash flow management.
Quarterly Net Loss Analysis: Net loss for the third quarter was $10.3 million, equating to a net loss of $0.14 per share compared to a net loss of $10.8 million or a net loss of $0.15 per share for the same period of the prior year, showing ongoing financial strain.
R&D Expense Increase: R&D expenses for the third quarter of 2024 were $5.9 million compared to $5.7 million in the third quarter of 2023, indicating rising costs in research and development without corresponding revenue growth.
Cost Management Efficiency: Sales, general and administrative expenses for the third quarter of 2024 were $7 million compared to $7.1 million in the third quarter of 2023, reflecting tight cost management but still high relative to revenue.
Cash Flow Concerns: Cash burn for the third quarter of 2024 was $8.9 million, and as of September 30, 2024, we have $45.8 million in cash and cash equivalents on our balance sheet, indicating a concerning cash flow situation.
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript
HYPR.O
1.71%